Navigation Links
Ohio's Regulation of RU-486 Clear and Constitutional, Should Be Upheld Argues AUL in Brief Filed Before Ohio Supreme Court
Date:10/16/2008

CHICAGO, Oct. 16 /PRNewswire-USNewswire/ -- Americans United for Life (AUL) today filed an amicus brief on behalf of ten U.S. Representatives supporting Ohio's regulation of the deadly abortion drug, RU-486.

AUL President Dr. Charmaine Yoest stated, "RU-486 has a proven track record of ruining and even ending women's lives. We must put a stop to abortionists' dangerous, off-label use of this drug. Ohio's statute is a step in the right direction, and as we argue in our brief, it should be upheld."

Added Denise Burke, AUL Vice President & Legal Director, "Abortionists readily admit to dispensing RU-486 in a manner contrary to the FDA's approved protocol. This puts women's health and lives at additional risk, and demonstrates yet again that the abortion industry puts profits above women's health."

Abortionists filed suit challenging the law, arguing Ohio's regulation of RU-486 is unconstitutional because the regulation's requirements are unclear. The state of Ohio and AUL counter that the Ohio regulation is definitive in its requirement that abortionists can only use the RU-486 drug regimen in the way in which it was tested by the FDA, which is clearly laid out in the drug manufacturer's instructions that accompany the drug.

"The argument that abortionists don't know how to correctly dispense RU-486 is nonsensical," stated AUL Staff Counsel Mailee Smith. "Physicians routinely follow the protocols approved by the FDA and described in manufacturer's instructions when dispensing other drugs. Ohio's regulation simply requires that abortionists do this with RU-486."

AUL's brief before the Ohio Supreme Court is available at

http://www.aul.org/xm_client/client_documents/briefs/Rogers_v_PlannedPa renthood.pdf and was filed on behalf of U.S. Representatives Roscoe Bartlett (MD), John A. Boehner (OH), Dan Burton (IN), Steve Chabot (OH), Trent Franks (AZ), Jim Jordan (OH), Robert E. Latta (OH), Joseph R. Pitts (PA), Jean Schmidt (OH), and Chris Smith (NJ).

In a related case challenging the same Ohio law, AUL filed a brief on behalf of a U.S. Senator and several U.S. Representatives before the Sixth Circuit. That brief is available at http://www.aul.org/xm_client/client_documents/briefs/AUL-PP_v_Strickland.pd f.

About Americans United for Life

Americans United for Life (AUL) is a nonprofit, public-interest law and policy organization whose vision is a nation in which every human being is welcomed in life and protected in law. The first national pro-life organization in America, AUL has been committed to defending human life through vigorous judicial, legislative, and educational efforts at both the federal and state levels since 1971. The Wall Street Journal has profiled AUL, and PBS' Frontline program chronicled AUL's successful efforts in Mississippi.

Media Contact

Matthew Eppinette

202-289-1479

matthew.eppinette@aul.org


'/>"/>
SOURCE Americans United For Life
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. R.J. Reynolds New Smokeless Products Will Appeal to Children and Show Need for FDA Regulation of Tobacco Products
2. FDA Proposes Regulations for Genetically Engineered Animals
3. Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers
4. VA Clarifies Voter Registration Regulations
5. New Assisted Living Regulations Do Little to Protect Consumers
6. California Health Plans Preparing for Language Assistance Regulation
7. SPOKESPERSON AVAILABILTY: Planned Parenthood President Available for Interviews on Proposed HHS Regulations
8. Public Interest Groups Back Federal Court Appeal to Implement New U.S. Patent Rules; Proposed Regulations Would Curtail Abusive Behavior by Patent Applicants
9. Proposed Medicare Regulations Threaten to End Millions of Free Meals Offered to Seniors During Education Seminars
10. CSPI to Call for Emergency Regulation for Produce Traceability
11. Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... While new U.S. opioid ... physicians are not legally required to follow them. In the absence of federal ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, strongly ...
(Date:5/23/2016)... ... ... the upcoming airing of Innovations with Ed Begley, Jr., ... 4:00pET via Fox Business. , The show will explore ... safely and rapidly develop cures for mosquito-borne, emerging infectious ...
(Date:5/23/2016)... , ... May 23, 2016 ... ... Size for Verification and Validation:, Tools to Safely Speed Your Device to ... http://www.fdanews.com/bestdevicesamplesizevv                  , Today's FDA inspectors focus like lasers on device ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... the action analytics leader as Chief Medical Officer. Dr. O’Connor’s deep expertise in ... product development and client services teams who deliver best-in-class solutions and transformative technologies ...
(Date:5/23/2016)... Valley, California (PRWEB) , ... May 23, 2016 ... ... clinical communications and solutions for healthcare providers announced today that AGNITY MobileCare™ Platform ... and health collaboration applications as a part of its M-Health Solution. Tech Mahindra ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Israel , May 19, 2016 ... the "Company"), an emerging global ophthalmic company focused on ... candidates which address ophthalmic conditions, announced today that it ... Italy ) for the manufacturing, distribution, marketing ... for the treatment of dry eye syndrome (DES) and ...
(Date:5/19/2016)... May 19, 2016 A ... World Biopsy Devices Market Opportunities and Forecasts, 2014 ... market generated $1,621 million in 2015. The MRI-guided ... and is expected to maintain this trend over ... http://photos.prnewswire.com/prnh/20140911/647229 ) , To know ...
(Date:5/19/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced ... of multiple cancer and hematological indications, will be presented ... titled " Clinical response in relapsed/refractory AML patients correlates ... a potent CXCR4 antagonist; results of a Phase 2a ... the European Hematology Association 21st Congress, to be held ...
Breaking Medicine Technology: